@article{29dd804bb7df471ea626066eaf3d2c2e,
title = "Treatment with docetaxel and cisplatin in advanced adrenocortical carcinoma, a phase II study",
abstract = "Adrenocortical carcinoma (ACC) is a rare disease with a poor response to chemotherapy. Cisplatin is the most widely investigated drug in the treatment of ACC and in vitro studies have indicated activity of taxanes. The objectives of this study were to evaluate the efficacy and toxicity of cisplatin combined with docetaxel as first-line treatment of advanced ACC.",
keywords = "Adrenal Cortex Neoplasms, Adrenocortical Carcinoma, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Cisplatin, Disease Progression, Female, Humans, Male, Middle Aged, Survival Analysis, Taxoids, Treatment Outcome, Young Adult",
author = "Thomas Urup and Pawlak, {W Z} and Petersen, {P M} and H Pappot and M R{\o}rth and G Daugaard",
year = "2013",
month = may,
day = "28",
doi = "10.1038/bjc.2013.229",
language = "English",
volume = "108",
pages = "1994--7",
journal = "B J C",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "10",
}